[RPRX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 585.50%
YoY- 181.02%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 596,000 565,748 575,700 571,000 457,486 6.83%
PBT 718,000 -610,030 53,671 367,000 1,446,528 -16.05%
Tax 223,000 139 46,974 -531,380 78,813 29.67%
NP 494,340 -610,169 7,904 171,000 1,420,396 -23.17%
Tax Rate -31.06% - -87.52% 144.79% -5.45% -
Total Cost 101,660 1,175,917 567,796 400,000 -962,910 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 82.94 -107.85 1.37 29.95 310.48 -28.09%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS 1.11 -1.38 0.02 0.44 4.01 -27.44%
EPS Diluted 1.11 -1.38 0.01 0.44 4.01 -27.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.